Core Scientific, Inc.
CORZ
$22.79
-$0.16-0.70%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 589.61% | 150.23% | -13.05% | -46.63% | -57.91% |
| Total Other Revenue | -55.19% | -47.23% | -15.70% | -43.63% | -55.20% |
| Total Revenue | 44.92% | -15.97% | -14.95% | -44.28% | -55.64% |
| Cost of Revenue | 19.39% | -45.43% | -19.17% | -28.04% | -29.84% |
| Gross Profit | 266.57% | 115.51% | 2,603.21% | -87.05% | -89.42% |
| SG&A Expenses | 37.36% | -9.62% | 58.24% | 81.44% | 94.34% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -38.64% | 1,631.30% | -5,418.93% | -5,202.23% | 2,068.32% |
| Total Operating Expenses | 19.14% | 15.20% | -4.39% | -24.96% | -2.66% |
| Operating Income | 38.84% | -118.47% | -20.33% | -422.89% | -157.72% |
| Income Before Tax | -160.12% | 155.21% | 67.80% | -16.39% | 173.34% |
| Income Tax Expenses | 192.68% | -74.67% | -6.72% | 9.72% | -0.49% |
| Earnings from Continuing Operations | -160.25% | 155.14% | 67.79% | -16.39% | 173.51% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -160.25% | 155.14% | 67.79% | -16.39% | 173.51% |
| EBIT | 38.84% | -118.47% | -20.33% | -422.89% | -157.72% |
| EBITDA | 68.13% | -1,754.40% | -171.70% | -109.25% | -117.32% |
| EPS Basic | -174.46% | 158.76% | 60.57% | 81.29% | 56.11% |
| Normalized Basic EPS | -109.51% | 201.66% | 75.11% | 35.09% | 333.05% |
| EPS Diluted | -185.52% | 140.47% | 60.57% | 81.21% | 59.92% |
| Normalized Diluted EPS | -110.96% | 169.92% | 75.11% | 35.09% | 359.65% |
| Average Basic Shares Outstanding | 2.45% | 4.40% | 8.92% | 78.14% | 36.47% |
| Average Diluted Shares Outstanding | -11.12% | 51.75% | 8.92% | 78.14% | 28.59% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |